These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10525729)

  • 1. Bisphosphonates: pharmacology, mechanisms of action and clinical uses.
    Russell RG; Croucher PI; Rogers MJ
    Osteoporos Int; 1999; 9 Suppl 2():S66-80. PubMed ID: 10525729
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular mechanisms of action of bisphosphonates.
    Rogers MJ; Frith JC; Luckman SP; Coxon FP; Benford HL; Mönkkönen J; Auriola S; Chilton KM; Russell RG
    Bone; 1999 May; 24(5 Suppl):73S-79S. PubMed ID: 10321934
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular and molecular mechanisms of action of bisphosphonates.
    Rogers MJ; Gordon S; Benford HL; Coxon FP; Luckman SP; Monkkonen J; Frith JC
    Cancer; 2000 Jun; 88(12 Suppl):2961-78. PubMed ID: 10898340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of action of bisphosphonates.
    Breuil V
    Rev Rhum Engl Ed; 1999 Jun; 66(6):339-43. PubMed ID: 10418063
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibitors of HMG-CoA reductase in prevention of osteoporosis and bone fractures. Similar mechanism of action of statins and bisphosphonates].
    Stajszczyk M; Mykała-Cieśla J
    Pol Arch Med Wewn; 2002 Jan; 107(1):85-91. PubMed ID: 12046350
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients.
    Jobke B; Milovanovic P; Amling M; Busse B
    Bone; 2014 Feb; 59():37-43. PubMed ID: 24211427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanisms of action of bisphosphonates and strontium ranelate].
    Vengerovskiĭ AI; Khlusov IA; Nechaev KA
    Eksp Klin Farmakol; 2014; 77(9):43-6. PubMed ID: 25365870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of bisphosphonates.
    Rogers MJ; Watts DJ; Russell RG
    Cancer; 1997 Oct; 80(8 Suppl):1652-60. PubMed ID: 9362432
    [No Abstract]   [Full Text] [Related]  

  • 9. Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages.
    Roelofs AJ; Thompson K; Ebetino FH; Rogers MJ; Coxon FP
    Curr Pharm Des; 2010; 16(27):2950-60. PubMed ID: 20722616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates: mechanism of action and role in clinical practice.
    Drake MT; Clarke BL; Khosla S
    Mayo Clin Proc; 2008 Sep; 83(9):1032-45. PubMed ID: 18775204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update.
    Fleisch H
    Horm Metab Res; 1997 Mar; 29(3):145-50. PubMed ID: 9137986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of bisphosphonates in prostate cancer.
    Oades GM; Coxon J; Colston KW
    Prostate Cancer Prostatic Dis; 2002; 5(4):264-72. PubMed ID: 12627210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bone-targeted Src tyrosine kinase inhibitor drug discovery.
    Shakespeare WC; Metcalf CA; Wang Y; Sundaramoorthi R; Keenan T; Weigele M; Bohacek RS; Dalgarno DC; Sawyer TK
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):729-41. PubMed ID: 14579523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the molecular mechanisms of action of bisphosphonates.
    Rogers MJ
    Curr Pharm Des; 2003; 9(32):2643-58. PubMed ID: 14529538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects of bisphosphonates in involutional osteoporosis.
    Ott SM
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S597-606. PubMed ID: 8122531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis.
    McClung MR
    Bone; 1996 Nov; 19(5 Suppl):195S-198S. PubMed ID: 8922662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates use in children.
    Sebestyen JF; Srivastava T; Alon US
    Clin Pediatr (Phila); 2012 Nov; 51(11):1011-24. PubMed ID: 22935217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of action in bisphosphonates].
    Hoshino H; Yamazaki K
    Clin Calcium; 2005 Jul; 15(7):88-92. PubMed ID: 15995302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates: pharmacology and effects on the growing skeleton.
    Papapoulos SE
    Acta Univ Carol Med (Praha); 1994; 40(1-4):29-32. PubMed ID: 9355668
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacokinetics of bisphosphonate.].
    Nakamura M; Koide M; Udagawa N
    Clin Calcium; 2016; 26(11):1561-1570. PubMed ID: 27777389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.